Target
5-hydroxytryptamine receptor 2C
Ligand
BDBM50342539
Substrate
n/a
Meas. Tech.
ChEMBL_744732 (CHEMBL1772753)
Ki
84±n/a nM
Citation
 Andrews, MDFish, PVBlagg, JBrabham, TKBrennan, PEBridgeland, ABrown, ADBungay, PJConlon, KMEdmunds, NJaf Forselles, KGibbons, CPGreen, MPHanton, GHolbrook, MJessiman, ASMcIntosh, KMcMurray, GNichols, CLRoot, JAStorer, RISutton, MRWard, RVWestbrook, DWhitlock, GA Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence. Bioorg Med Chem Lett 21:2715-20 (2011) [PubMed]  Article 
Target
Name:
5-hydroxytryptamine receptor 2C
Synonyms:
5-HT-2C | 5-HT2C | 5-HT2C-INI | 5-HT2c VGI | 5-HTR2C | 5-hydroxytryptamine receptor 1C | 5-hydroxytryptamine receptor 2C (5-HT-2C) | 5-hydroxytryptamine receptor 2C (5HT-2C) | 5HT-1C | 5HT2C_HUMAN | HTR1C | HTR2C | Serotonin (5-HT3) receptor | Serotonin 2c (5-HT2c) receptor | Serotonin Receptor 2C
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
51836.79
Organism:
Homo sapiens (Human)
Description:
P28335
Residue:
458
Sequence:
MVNLRNAVHSFLVHLIGLLVWQCDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV
  
Inhibitor
Name:
BDBM50342539
Synonyms:
2-(3-chlorobenzyl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine | CHEMBL1770382
Type:
Small organic molecule
Emp. Form.:
C15H16ClN3
Mol. Mass.:
273.761
SMILES:
Clc1cccc(Cc2ncc3CCNCCc3n2)c1
Structure:
Search PDB for entries with ligand similarity: